Protagen Ag

Algiax Pharmaceuticals Gmbh

Henkel Ag & Company, Kgaa

Stefan Müllner

Ralf Paus

Heike Göhler

Angelika Lüking

Petra Rengers

Peter Schulz-Knappe

Birgit Hasse

Guido Koopmans

Jessica Schwermann

Angelika Lueking

Edo Hoting

The present invention relates to a novel method for diagnosing high-affinity binders, in particular antibodies or autoantibodies, and the identification, characterization and selection of marker sequences and diagnostic use thereof, in particular in the form of a panel. The invention also relates to a singleplex assay in which the discovered selection of marker sequences is used in the form of a panel and high-affinity binders are detected using a single signal.

Method for diagnosis of high-affinity binders and marker sequences

The present invention relates to a method for the diagnosis and/or risk stratification of neuromyelitis optica (abbreviated NMO), wherein a determination from a body sample of a patient/test subject is performed by means of artificial aquaporin-4 peptides. The invention further relates to a kit and to new artificial aquaporin-4 peptides as such.

Method for the diagnosis of neuromyelitis optica

The invention relates to the use of polycycloolefins in electronic devices and more specifically to the use of such polycycloolefins as interlayers applied to insulating layers used in electronic devices, the electronic devices that encompass such polycycloolefin interlayers and processes for preparing such polycycloolefin interlayers and electronic devices.

Use of leflunomide and malononitrilamides

Growing community of inventors

Langenfeld, Germany

Stefan Müllner